Alma BioTherapeutics

Alma's treatment has the potential to treat the underlying cause of autoimmune disease and resolve inflammation without suppressing the immune system.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Lyon, France
  • Currency EUR
  • Founded November 2013
  • Employees 4
  • Incorporation Type Other
  • Website alma-bio.com

Company Summary

Alma Bio Thrapeutics is moving the needle on autoimmune disease treatment.

Our therapeutic approach derives from the intricate knowledge of body molecules that manage inflammation and mechanisms underlying autoimmune disease.

We employ the body`s immune regulators to resolve pathological inflammation without compromising the essential functions of the immune system.

The treatment is self-limiting and stops acting once inflammation is resolved.

Team

  • Dr. Binah Baum
    Entrepreneur, co-founder and CEO

    Binah Baum is a Female leader in Biotech; she has clocked 30 years experience in the startup segment of the biopharmaceutical industry. She has nurtured companies from all approaches as a venture capitalist, bioincubator manager and, now, CEO.

  • Prof. Irun Cohen, MD
    Co-founder and Inventor

    Emeritus Mauerberger Professor of Immunology at the Department of Immunology of the Weizmann Institute of Science; Ex Director, European Collaboration on T Cell Vaccination; Ex Director, Robert Koch-Minerva Center for Research in Autoimmune Diseases.
    For his work on autoimmunity - he was awarded the Robert Koch Prize (Germany), the Teva Founders Prize, the AESKU Prize and a European Federation of Immunological Societies Prize, among others.

  • Dr. Denis Ravel
    Director of preclinical development

    Dr. Denis Ravel brings 30 years’ experience as bio-pharma executive for both major and medium size biopharmaceutical companies (Servier, Genset / MerckSerono, Diatos). Dr.Ravel specialises in ushering drugs from concept to the clinic.

Previous Investors

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free